Tardive Dyskinesia Clinical Trials

Tardive Dyskinesia Trials Within Driving Distance of Charlotte. Here Is What You Should Know.

Tardive dyskinesia is the involuntary, repetitive movement disorder that can develop after months or years of taking antipsychotic medications. Tongue movements. Lip smacking. Facial grimacing. Sometimes the trunk and limbs. The movements are not under your control and they do not stop just because you wish they would.

There are two FDA-approved TD treatments. Valbenazine (Ingrezza) and deutetrabenazine (Austedo). They both work by quieting a specific dopamine pathway in the brain (called VMAT2). They help most people. They do not help everyone. The trial featured on this page is specifically for people whose TD is still active despite already being on one of these medications, or who stopped taking one and the symptoms came back.

There are no TD trials enrolling in Charlotte itself right now. The closest sites are in Atlanta and Richmond. That sounds like a deal-breaker until you realize the trial is open-label (you definitely get the active drug, not a placebo) and travel is reimbursed. For something this specific, traveling 3-5 hours can be the right call.

New to clinical trials? Read our Clinical Trials 101 guide →

Why Travel for a TD Trial

TD is rare enough that there are not many trials running at any given time. The active studies tend to cluster at sites that already have experience with movement disorder ratings. The Marietta and Richmond sites are both Neurocrine-affiliated, which means they have run TD trials before. Their staff knows the AIMS rating scale and what to look for.

Visits in this kind of trial are spaced out. Screening, baseline, then visits roughly every 4 weeks for 6 months. That works out to about 10 trips. With travel reimbursement and hotel coverage typically included for distant participants, the out-of-pocket cost is usually close to zero. The compensation per visit covers your time and is on top of travel.

For a Charlotte resident, that is roughly one travel day per month for half a year. Not nothing. But far more manageable than people assume when they first see “Atlanta” or “Richmond” on a trial listing.

What to Look for in a TD Clinical Trial

First, check the open-label status. The Valbenazine Phase 4 trial is open-label, which means there is no placebo. Everyone enrolled gets the active medication. That is a meaningful difference from earlier-phase trials where you might be assigned a sugar pill.

Second, the eligibility. This study is for adults 18+ with a confirmed psychiatric diagnosis (schizophrenia, schizoaffective disorder, bipolar disorder, or major depressive disorder) and at least mild TD that has lasted 3 months or longer. You also need to either currently be taking deutetrabenazine and still have symptoms, or have stopped a previous TD treatment with TD coming back.

Third, ask about the visit schedule and whether visits can be combined. Some sites can stack assessments so you do an extended morning visit instead of two short appointments on different days. That matters a lot when each visit means a hotel night.

Finally, the travel reimbursement details. Get them in writing during your screening call. How is mileage paid (per mile, by IRS rate, flat fee?). Is the hotel booked by the site or do you book and submit receipts? Are meals covered. These are normal questions and the site coordinator will answer all of them.

Charlotte Research Will Likely Add TD Studies Soon

Charlotte is growing fast as a clinical research market. The metro now has roughly a dozen serious research sites, several of them focused on psychiatry and CNS conditions. Atrium Health alone has 161+ active studies. Monroe Biomedical, just south of Charlotte, is ranked among the top 5 highest-enrolling sites in the entire country.

New Hope Clinical Research in SouthPark already runs trials for major depression, schizophrenia, and bipolar disorder. Those are the same patient populations that develop TD. As the next wave of TD studies opens, Charlotte sites are well-positioned to participate. If you want to be notified when a TD trial opens locally, get on our list and we will reach out the moment one starts enrolling.

In the meantime, the Atlanta and Richmond sites listed above are real options worth considering, especially if your TD has not responded fully to current treatment.